CD8A and metabolic dysfunction-associated steatohepatitis: To sum up, in our mouse model of NASH and human NASH samples, upregulation of the inhibitory receptors PD1 on hepatic CD8 T cells and 2B4 on hepatic CD4 and CD8 T cells seems to limit T cell mediated liver damage.